Clinical updates, including trial initiations, enrollment status and data readouts and publications: Dermtech, Prognomiq.

Med-tech firms raising money in public or private financings, including: Imbed Biosciences, Niterra, Quanthealth.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Accenture, Aditxt, Bristol Myers, C2i Genomics, Cue Health, Esight, Evotec, GE Healthcare, Gentex, guardant, Hikma, Livanova, MDNA, MIM Software, Nanostring Technologies, Pangia Biotech, Pearsanta, Quantumhealth, Quest Diagnostics, Rivermark Medical, Stereotaxis, Tandem, Veracyte.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Butterfly Network, Medtronic, Qiagen, Zoll.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Better Therapeutics, Biocare Medical, Burning Rock, Curadh MTR, Endoquest Robotics, Endotronix, Glooko, Histosonics, Illumina, Janssen, J&J, Maxim Biomedical, Molecular Instruments, Northstar Medical, Omnivision, Orasure Technologies, Perspective Therapeutics, Sapphiros, Somalogic, Standard Biotools, Sonde Health, Varian, Will Semiconductor.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Medtronic, Nanowear.

Med-tech firms raising money in public or private financings, including: Aditxt, LEM Surgical, Radionetics.

New hires and promotions in the med-tech industry, including: Bio-Techne, Delfi Diagnostics, Glytec, Healthy.io, Illumina, Simbiosys, Zimmer Biomet.

Med-tech financings exceeded $1 billion for the third consecutive month, reaching a total of $1.07 billion in transactions in December. In November, med-techs raised $1.02 billion, with $1.23 billion raised in October. The overall average for financings in 2023 stands at $1.47 billion per month, down from a monthly average of $3.19 billion the previous year.